| Chaperone mediated autophagy degrades TDP-43 protein and is affected by TDP-43 aggregation F Ormeño, J Hormazabal, J Moreno, F Riquelme, J Rios, A Criollo, ... Frontiers in molecular neuroscience 13, 19, 2020 | 46 | 2020 |
| Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort E Rey-Jurado, Y Espinosa, C Astudillo, LJ Cortés, J Hormazabal, ... Journal of Allergy and Clinical Immunology 150 (5), 1074-1085. e11, 2022 | 17 | 2022 |
| Evaluation of the immune response induced by CoronaVac 28-day schedule vaccination in a healthy population group A Escobar, FE Reyes-López, ML Acevedo, L Alonso-Palomares, ... Frontiers in immunology 12, 766278, 2022 | 16 | 2022 |
| Chaperone mediated autophagy contributes to the newly synthesized histones H3 and H4 quality control J Hormazabal, F Saavedra, C Espinoza-Arratia, NW Martinez, T Cruces, ... Nucleic Acids Research 50 (4), 1875-1887, 2022 | 10 | 2022 |
| Immunization and SARS-CoV-2 antibody seroprevalence in a country with high vaccination coverage: Lessons from Chile X Aguilera, C González, M Apablaza, P Rubilar, G Icaza, ... Vaccines 10 (7), 1002, 2022 | 7 | 2022 |
| SARS-CoV-2 neutralizing antibodies in Chile after a vaccination campaign with five different schemes X Aguilera, J Hormazábal, C Vial, LJ Cortes, C González, P Rubilar, ... Vaccines 10 (7), 1051, 2022 | 6 | 2022 |
| A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients MC Poli, C Vial, E Rey-Jurado, N González, LJ Cortés, J Hormazabal, ... Vaccines 11 (5), 1012, 2023 | 4 | 2023 |
| Seroprevalence of natural and acquired immunity against the SARS-CoV-2 virus in a population cohort from two Chilean cities, 2020–2022 L Núñez-Franz, M Ramírez-Santana, P Rubilar, C Vial, M Apablaza, ... Viruses 15 (1), 201, 2023 | 4 | 2023 |
| Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study J Hormazábal, L Nuñez-Franz, P Rubilar, M Apablaza, C Vial, LJ Cortés, ... Vaccine: X 15, 100372, 2023 | | 2023 |
| A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients MC Poli Harlowe, MC Vial Cox, E Rey, N González, L Cortés, ... | | 2023 |
| A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients. Vaccines 2023, 11, 1012 MC Poli, C Vial, E Rey-Jurado, N González, LJ Cortés, J Hormazabal, ... | | 2023 |
| Immune response against SARS-CoV-2 of primary healthcare personnel in a commune of Santiago, Chile: follow-up at 6 months A Olea, I Matute, M Hirmas, C González, M Iruretagoyena, J Munita, ... medRxiv, 2022.08. 03.22278369, 2022 | | 2022 |
| Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort E Rey, Y Espinosa, C Astudillo, L Jimena, J Hormazábal, L Noguera, ... | | 2022 |
| SARS-CoV-2 neutralizing antibodies in Chile after a vaccination campaign with five different schemes (preprint) X Aguilera, J Hormazabal, C Vial, LJ Cortes, CW Gonzalez, P Rubilar, ... | | 2022 |
| SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes. Vaccines 2022, 10, 1051 X Aguilera, J Hormazábal, C Vial, LJ Cortes, C González, P Rubilar, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation I Alfaro, F Ormeño, J Hormazábal, J Moreno, F Riquelme, J Ríos, A Criollo, ... | | 2020 |
| Factores que influyen en la respuesta de anticuerpos neutralizantes al virus SARS-CoV-2 original y su variante Ómicron, un estudio basado en la población. J Hormazabal Departamento de Salud Pública, Facultad de Medicina, Universidad Católica …, 0 | | |
